Skip to Main Content

Paper Details

A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
Elife
17
2021
ABO, ABO protein, ABO signal, CD209, COVID, COVID-, COVID-19, FAS, Fas, OAS1, SARS-, SARS-CoV, SARS-CoV-2, soluble Fas, spike protein
Author NameAffiliation
Valur Emilsson
Valur EmilssonUniversity of Iceland
Vilmundur Gudnason
Vilmundur GudnasonUniversity of Iceland
Ellen M McDonagh
Ellen M McDonaghEuropean Bioinformatics Institute (EMBL-EBI)
Maya GhoussainiWellcome Sanger Institute
Maya Ghoussaini
Ian DunhamWellcome Sanger Institute
Ian Dunham
Ian DunhamEuropean Bioinformatics Institute (EMBL-EBI)
Ian DunhamWellcome Sanger Institute
Ian Dunham
Ian DunhamEuropean Bioinformatics Institute (EMBL-EBI)
  • 1 - 14

Datasets

Dataset
Description
Source Link
Open TargetsTarget Validation platform: links between potential drug targets and diseasesLink
Open TargetsTarget Validation platform: links between potential drug targets and diseasesLink
Open TargetsTarget Validation platform: links between potential drug targets and diseasesLink
Open TargetsTarget Validation platform: links between potential drug targets and diseasesLink
Open TargetsTarget Validation platform: links between potential drug targets and diseasesLink
Open TargetsTarget Validation platform: links between potential drug targets and diseasesLink
Open TargetsTarget Validation platform: links between potential drug targets and diseasesLink
Open TargetsTarget Validation platform: links between potential drug targets and diseasesLink
Open TargetsTarget Validation platform: links between potential drug targets and diseasesLink
Release 1.2